“Is KRAS Druggable?” Experts in Pancreatic Cancer and KRAS Discuss Tough Questions

http://youtu.be/S-AqilU-T64 At the Pancreatic Cancer Action Network’s Annual Scientific Meeting 2016, three world-renowned KRAS experts sat down to discuss KRAS and its critical role in pancreatic cancer progression and to encourage young researchers to enter the field. Dafna Bar-Sagi, PhD, Channing Der, PhD, and Frank McCormick, PhD, FRS, have each received research funding from the Pancreatic Cancer Action Network. Drs. Bar-Sagi and Der are part of the organization’s Scientific and Medical Advisory Board, and Dr. McCormick is an emeritus member.